Home/Filings/4/0000950170-24-052788
4//SEC Filing

Crombez Eric 4

Accession 0000950170-24-052788

CIK 0001515673other

Filed

May 2, 8:00 PM ET

Accepted

May 3, 3:23 PM ET

Size

4.8 KB

Accession

0000950170-24-052788

Insider Transaction Report

Form 4
Period: 2024-05-02
Crombez Eric
EVP and Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2024-05-02$43.66/sh354$15,45648,431 total
Footnotes (2)
  • [F1]Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
  • [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Documents

1 file

Issuer

Ultragenyx Pharmaceutical Inc.

CIK 0001515673

Entity typeother

Related Parties

1
  • filerCIK 0001653052

Filing Metadata

Form type
4
Filed
May 2, 8:00 PM ET
Accepted
May 3, 3:23 PM ET
Size
4.8 KB